WINNINGHAM RICK E (Chief Executive Officer) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2023ACC: 0001415889-23-004277
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+330K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
330K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+330K
Price / share
—
Trade value
—
% of position
25.1%
3/1/2023
1.31M→1.64M
Total
Net shares
+330K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/1/2023 | A · Award | +330K | — | — | 25.1% | 1.31M | 1.64M |
| Total | +330K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported